+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Latent TB Testing Market - Global Forecast 2026-2032- Product Image
Latent TB Testing Market - Global Forecast 2026-2032- Product Image
Sale

Latent TB Testing Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055453
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Latent TB Testing Market is projected to reach USD 516.76 Million in 2026. It is expected to continue growing at a CAGR of 8.09%, reaching USD 822.51 Million by 2032.

Latent TB Testing: Executive Summary

Latent tuberculosis (TB) testing identifies people infected with Mycobacterium tuberculosis who do not have active TB disease. It supports preventive treatment, contact investigation, occupational health, immigration screening, and targeted testing of populations with elevated exposure or progression risk. The field is shaped by public-health priorities, test accessibility, laboratory capacity, clinical interpretation, and follow-up adherence.

How Latent TB Testing Is Evolving

The testing landscape is shifting from broad, untargeted screening toward risk-based strategies that connect testing with prevention and case-finding pathways. Interferon-gamma release assays and tuberculin skin testing remain central approaches, while improvements in specimen handling, laboratory workflows, digital reporting, and clinical decision support are helping programs manage complex screening environments. Persistent challenges include distinguishing infection from disease, addressing Bacille Calmette-Guérin vaccination effects when interpreting results, reducing loss to follow-up, and ensuring equitable access in underserved communities.

Artificial Intelligence Strengthens Screening Workflows

Artificial intelligence can support latent TB testing by improving eligibility assessment, identifying people who may benefit from screening, prioritizing follow-up, and detecting inconsistencies in clinical or laboratory records. It can also assist with workflow automation, quality monitoring, multilingual communication, and linkage between test results and preventive-treatment services. These applications should remain clinician-supervised and validated across demographic groups, because biased training data, incomplete records, false-positive prioritization, privacy risks, and unclear accountability can undermine trust and patient safety.

Regional Insights Across Six Geographies

North America emphasizes targeted testing among contacts, migrants, healthcare personnel, and other risk groups, supported by established laboratory and public-health infrastructure. Latin America continues to balance urban transmission concerns, uneven diagnostic access, and the need to integrate testing with primary care and contact investigation. Europe benefits from coordinated surveillance and strong clinical systems, while national policies differ in screening eligibility and use of diagnostic methods. The Middle East faces varied migration patterns and healthcare capacity, making standardized referral and follow-up important. Africa requires stronger integration of latent TB services with HIV care, contact management, and broader health programs. Asia-Pacific combines substantial TB exposure in parts of the region with advanced diagnostic capacity in others, creating a need for locally adapted, risk-based approaches.

Group-Level Priorities: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members can benefit from shared protocols, cross-border continuity of care, and stronger integration of testing into primary-health and contact-tracing systems. BRICS countries face diverse epidemiological and health-system conditions, making adaptable national guidelines, laboratory quality assurance, and high-risk population targeting essential. The European Union can advance interoperability, migrant-health coordination, and consistent interpretation across member states. G7 systems are positioned to improve digital linkage, occupational screening, and evidence-based stewardship of testing resources. GCC countries require scalable services for mobile and expatriate populations, with clear referral and documentation pathways. NATO members can strengthen standardized screening and medical readiness while protecting service-member confidentiality and ensuring continuity during deployments and relocation.

Country Insights: Diverse Implementation Contexts

Australia combines strong public-health capability with geographically dispersed populations, requiring accessible referral pathways. Brazil benefits from integrating latent TB testing with primary care, contact investigation, and preventive treatment. Canada must account for regional variation, Indigenous health inequities, and migrant screening needs. China’s large and diverse health system requires consistent quality assurance and targeted implementation. France, Germany, Italy, and Spain continue to benefit from coordinated clinical and public-health pathways, particularly for contacts, migrants, and healthcare workers. India requires broad primary-care integration and reliable follow-up across varied settings. Japan and South Korea have mature health systems but must maintain risk-based screening and support aging populations. Mexico can strengthen decentralization, laboratory access, and contact management. Russia requires dependable diagnostic services and linkage to preventive care. The United Kingdom and United States can further align testing with risk assessment, preventive treatment, and digitally supported follow-up.

Actions for Leaders: Link Testing to Prevention and Equity

Industry leaders should define clear eligibility criteria, pair every test with a documented follow-up pathway, and measure completion from screening through preventive treatment. They should invest in laboratory quality systems, staff training, interoperable records, and patient communication that explains uncertainty and next steps. Programs should monitor turnaround time, invalid or indeterminate results, treatment initiation, treatment completion, and disparities by geography and population group. AI deployments should use transparent governance, human review, privacy safeguards, prospective validation, and routine bias audits. Partnerships with public-health agencies, primary-care providers, employers, community organizations, and affected populations can improve trust and continuity.

Research Methodology for a Reliable Executive View

This executive summary uses a structured qualitative synthesis of established latent TB testing concepts, including test characteristics, clinical pathways, public-health use cases, implementation barriers, regional health-system differences, and responsible technology adoption. Findings are organized across the requested regions, country groupings, and countries, with emphasis on verifiable operational and policy themes rather than market estimates. Interpretation should be checked against current national guidelines, regulatory requirements, epidemiological surveillance, laboratory standards, and peer-reviewed clinical evidence before informing local decisions.

Conclusion: Make Latent TB Testing Actionable

Latent TB testing is most effective when it is targeted to meaningful risk, interpreted within a clinical context, and directly connected to preventive treatment and follow-up. Regional and country differences make one-size-fits-all implementation unsuitable, but common priorities are clear: strengthen quality, improve equity, integrate services, and use digital and AI tools responsibly. Leaders that focus on the complete patient pathway-not testing alone-can improve the public-health value, reliability, and acceptability of latent TB programs.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Latent TB Testing Market, by Product Type
7.1. Introduction
7.2. Instruments
7.3. Kits
7.4. Reagents
8. Latent TB Testing Market, by Test Type
8.1. Introduction
8.2. Interferon Gamma Release Assays (IGRAs)
8.2.1. Chemiluminescence
8.2.2. ELISA (Enzyme-Linked Immunosorbent Assay)
8.3. Tuberculin Skin Test (TST)
8.3.1. Intradermal
8.3.2. Multipuncture
9. Latent TB Testing Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Plasma
9.4. Serum
10. Latent TB Testing Market, by Application
10.1. Introduction
10.2. Diagnostic Testing
10.3. Research
10.3.1. New Test Development
10.3.2. Vaccine Development
10.4. Screening
10.4.1. Health Check-Ups
10.4.2. Immigration Screening
11. Latent TB Testing Market, by End User
11.1. Introduction
11.2. Diagnostic Centres
11.3. Hospital Laboratories
11.4. Public Health Departments
11.5. Research Institutes
12. Latent TB Testing Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Latent TB Testing Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Latent TB Testing Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Beckman Coulter, Inc.
16.3. Becton, Dickinson and Company (BD)
16.4. Bio-Rad Laboratories, Inc.
16.5. Biocare Medical, LLC
16.6. bioMérieux SA
16.7. Cepheid, Inc.
16.8. Danaher Corporation
16.9. DiaSorin S.p.A.
16.10. Eiken Chemical Co., Ltd.
16.11. ElitechGroup SAS by Bruker Company
16.12. F. Hoffmann-La Roche AG
16.13. Fujifilm Holdings Corporation
16.14. Hologic, Inc.
16.15. Mabtech AB
16.16. Meridian Bioscience, Inc.
16.17. Oxford Immunotec Limited by PerkinElmer, Inc.
16.18. Qiagen N.V.
16.19. Siemens Healthineers AG
16.20. Thermo Fisher Scientific Inc.
16.21. Tosoh Bioscience, Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Latent TB Testing Market, Years Considered for the Study
FIGURE 2. Global Latent TB Testing Market, Research Design
FIGURE 3. Global Latent TB Testing Market, Research Framework
FIGURE 4. Global Latent TB Testing Market, Data Triangulation
FIGURE 5. Global Latent TB Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Latent TB Testing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Latent TB Testing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Latent TB Testing Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 9. Global Latent TB Testing Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Latent TB Testing Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Latent TB Testing Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Latent TB Testing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Latent TB Testing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Latent TB Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Latent TB Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Latent TB Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Latent TB Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Latent TB Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Latent TB Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Latent TB Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Latent TB Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Latent TB Testing Market Segmentation & Coverage
TABLE 2. Global Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 14. Global Interferon Gamma Release Assays (IGRAs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Interferon Gamma Release Assays (IGRAs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Interferon Gamma Release Assays (IGRAs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Chemiluminescence Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Chemiluminescence Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Chemiluminescence Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global ELISA (Enzyme-Linked Immunosorbent Assay) Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global ELISA (Enzyme-Linked Immunosorbent Assay) Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global ELISA (Enzyme-Linked Immunosorbent Assay) Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Tuberculin Skin Test (TST) Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Tuberculin Skin Test (TST) Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Tuberculin Skin Test (TST) Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Intradermal Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Intradermal Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Intradermal Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Multipuncture Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Multipuncture Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Multipuncture Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 33. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 43. Global Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Diagnostic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global New Test Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global New Test Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global New Test Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Vaccine Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Vaccine Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Vaccine Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Health Check-Ups Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Health Check-Ups Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Health Check-Ups Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Immigration Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Immigration Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Immigration Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Global Diagnostic Centres Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Diagnostic Centres Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Diagnostic Centres Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Hospital Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Hospital Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Hospital Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Public Health Departments Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Public Health Departments Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Public Health Departments Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Latent TB Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Latent TB Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. North America Latent TB Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. North America Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. North America Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 91. North America Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 92. North America Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 93. North America Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 94. North America Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. North America Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 96. North America Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 97. North America Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Latin America Latent TB Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Latin America Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Latin America Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 101. Latin America Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 102. Latin America Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 103. Latin America Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 104. Latin America Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Latin America Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 106. Latin America Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 107. Latin America Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Europe Latent TB Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Europe Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. Europe Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 111. Europe Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 112. Europe Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 113. Europe Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 114. Europe Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. Europe Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 116. Europe Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 117. Europe Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. Middle East Latent TB Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Middle East Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. Middle East Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 121. Middle East Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 122. Middle East Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 123. Middle East Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 124. Middle East Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Middle East Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 126. Middle East Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 127. Middle East Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Africa Latent TB Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Africa Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. Africa Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 131. Africa Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 132. Africa Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 133. Africa Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 134. Africa Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Africa Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 136. Africa Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 137. Africa Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Global Latent TB Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. ASEAN Latent TB Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. ASEAN Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. ASEAN Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 142. ASEAN Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 143. ASEAN Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 144. ASEAN Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 145. ASEAN Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. ASEAN Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 147. ASEAN Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 148. ASEAN Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. GCC Latent TB Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. GCC Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. GCC Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 152. GCC Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 153. GCC Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 154. GCC Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 155. GCC Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. GCC Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 157. GCC Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 158. GCC Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. European Union Latent TB Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. European Union Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. European Union Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 162. European Union Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 163. European Union Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 164. European Union Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 165. European Union Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. European Union Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 167. European Union Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 168. European Union Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. BRICS Latent TB Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. BRICS Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. BRICS Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 172. BRICS Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 173. BRICS Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 174. BRICS Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 175. BRICS Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. BRICS Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 177. BRICS Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 178. BRICS Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. G7 Latent TB Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. G7 Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. G7 Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 182. G7 Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 183. G7 Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 184. G7 Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 185. G7 Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. G7 Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 187. G7 Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 188. G7 Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. NATO Latent TB Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. NATO Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. NATO Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 192. NATO Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 193. NATO Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 194. NATO Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 195. NATO Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. NATO Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 197. NATO Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 198. NATO Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Global Latent TB Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 200. United States Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 201. United States Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. United States Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 203. United States Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 204. United States Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 205. United States Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 206. United States Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. United States Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 208. United States Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 209. United States Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Canada Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 211. Canada Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. Canada Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 213. Canada Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 214. Canada Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 215. Canada Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 216. Canada Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Canada Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 218. Canada Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 219. Canada Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Mexico Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 221. Mexico Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Mexico Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 223. Mexico Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 224. Mexico Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 225. Mexico Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 226. Mexico Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Mexico Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 228. Mexico Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 229. Mexico Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Brazil Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 231. Brazil Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Brazil Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 233. Brazil Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 234. Brazil Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 235. Brazil Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 236. Brazil Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. Brazil Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 238. Brazil Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 239. Brazil Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. United Kingdom Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 241. United Kingdom Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. United Kingdom Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 243. United Kingdom Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 244. United Kingdom Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 245. United Kingdom Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 246. United Kingdom Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. United Kingdom Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 248. United Kingdom Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 249. United Kingdom Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Germany Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 251. Germany Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 252. Germany Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 253. Germany Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 254. Germany Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 255. Germany Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 256. Germany Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. Germany Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 258. Germany Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 259. Germany Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. France Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 261. France Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. France Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 263. France Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 264. France Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 265. France Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 266. France Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. France Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 268. France Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 269. France Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Russia Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 271. Russia Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. Russia Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 273. Russia Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 274. Russia Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 275. Russia Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 276. Russia Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. Russia Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 278. Russia Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 279. Russia Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. Italy Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 281. Italy Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 282. Italy Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 283. Italy Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 284. Italy Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 285. Italy Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 286. Italy Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. Italy Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 288. Italy Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 289. Italy Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. Spain Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 291. Spain Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 292. Spain Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 293. Spain Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 294. Spain Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 295. Spain Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 296. Spain Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. Spain Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 298. Spain Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 299. Spain Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. China Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 301. China Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 302. China Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 303. China Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 304. China Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 305. China Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 306. China Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. China Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 308. China Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 309. China Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. India Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 311. India Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 312. India Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 313. India Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 314. India Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 315. India Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 316. India Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. India Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 318. India Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 319. India Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. Japan Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 321. Japan Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 322. Japan Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 323. Japan Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 324. Japan Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 325. Japan Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 326. Japan Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 327. Japan Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 328. Japan Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 329. Japan Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 330. Australia Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 331. Australia Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 332. Australia Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 333. Australia Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 334. Australia Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 335. Australia Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 336. Australia Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 337. Australia Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 338. Australia Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 339. Australia Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 340. South Korea Latent TB Testing Market Size, 2017-2032 (USD Million)
TABLE 341. South Korea Latent TB Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 342. South Korea Latent TB Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 343. South Korea Latent TB Testing Market Size, by Interferon Gamma Release Assays (IGRAs), 2017-2032 (USD Million)
TABLE 344. South Korea Latent TB Testing Market Size, by Tuberculin Skin Test (TST), 2017-2032 (USD Million)
TABLE 345. South Korea Latent TB Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 346. South Korea Latent TB Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 347. South Korea Latent TB Testing Market Size, by Research, 2017-2032 (USD Million)
TABLE 348. South Korea Latent TB Testing Market Size, by Screening, 2017-2032 (USD Million)
TABLE 349. South Korea Latent TB Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 350. Global Latent TB Testing Market Share, by Key Player, 2025
TABLE 351. Global Latent TB Testing Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Biocare Medical, LLC
  • bioMérieux SA
  • Cepheid, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eiken Chemical Co., Ltd.
  • ElitechGroup SAS by Bruker Company
  • F. Hoffmann-La Roche AG
  • Fujifilm Holdings Corporation
  • Hologic, Inc.
  • Mabtech AB
  • Meridian Bioscience, Inc.
  • Oxford Immunotec Limited by PerkinElmer, Inc.
  • Qiagen N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience, Inc.

Related Topics

Related Reports

Latent TB Testing Market (2026 Edition) - Product Image

Latent TB Testing Market (2026 Edition)

  • Report
  • 198 Pages
  • Global
From
Tuberculosis Diagnostics Market - Global Forecast 2026-2032 - Product Image

Tuberculosis Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Latent TB Diagnostics Market 2025-2029 - Global Market Analysis and Forecasts by Assay, Risk Factor, and Lab/Place, with Executive and Consultant Guides - Product Image

Latent TB Diagnostics Market 2025-2029 - Global Market Analysis and Forecasts by Assay, Risk Factor, and Lab/Place, with Executive and Consultant Guides

  • Report
  • 322 Pages
  • Global
From
Tuberculosis Testing Market - Global Forecast 2026-2032 - Product Image

Tuberculosis Testing Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand, Test, Application, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand, Test, Application, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.